Skip to main content
. 2020 Nov 2;2(2):fcaa181. doi: 10.1093/braincomms/fcaa181

Figure 1.

Figure 1

Characteristics of patients with ICIAM. (A) Diagnostic features of ICIAM in the current cohort. Numbers in red and blue indicate numbers of patients with oculobulbar and generalized phenotype, respectively. Numbers in parenthesis indicate numbers of patients who underwent muscle biopsy and had pathologically defined myopathy. There are two patients with possible ICIAM: one oculobulbar patient with abnormal MRI of extraocular muscles (CK and EMG not performed) and one generalized patient with markedly elevated CK level (EMG and MRI not performed). (B) Cancer types in the current cohort. (C) Immune checkpoint inhibitors used in the current cohort. (D) Coexisting immune-related adverse events in the current cohort.